These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 488132)

  • 1. The metabolism of saddamine in man: the fate of the benzylamine moiety of saddamine.
    Al-Ani MR; Wood SG; Lawson A
    Eur J Drug Metab Pharmacokinet; 1979; 4(2):117-9. PubMed ID: 488132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippuric acid excretion after benzylamine ingestion in man.
    Wood SG; Al-Ani MR; Lawson A
    Br J Ind Med; 1978 Aug; 35(3):230-1. PubMed ID: 698137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLC determination of purity of Schiff bases bakrine and saddamine.
    Wood SG; Al-Ani MR; Lawson A
    J Pharm Sci; 1979 Mar; 68(3):374-6. PubMed ID: 423134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Methyl-benzylamine, a metabolite of pargyline in man.
    Pirisino R; Ciottoli GB; Buffoni F; Anselmi B; Curradi C
    Br J Clin Pharmacol; 1979 Jun; 7(6):595-8. PubMed ID: 465282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the major urinary metabolites of saddamine and aspirin using thin-layer chromatography.
    Al-Ani MR; Wood SG; Lawson A
    J Chromatogr; 1978 Dec; 166(2):626-31. PubMed ID: 748364
    [No Abstract]   [Full Text] [Related]  

  • 6. The metabolism of salicylidene benzylamine, a pro-drug for salicylate, in rats and dogs.
    Kirkpatrick D; Hawkins DR; Chasseaud LF; Finn CM; Conway B; Al-Ani MR; Al-Sayyab AF
    Xenobiotica; 1983 Jan; 13(1):53-64. PubMed ID: 6858201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzylamine metabolism at low O2 concentrations. Relative sensitivities of monoamine oxidase, aldehyde dehydrogenase and hippurate synthesis to hypoxia.
    Jones DP
    Biochem Pharmacol; 1984 Feb; 33(3):413-7. PubMed ID: 6704160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
    Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
    Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic disposition of 14C-ciramadol in humans.
    Sisenwine SF; Liu AL; Tio C; Kimmel H; Freeland G
    Xenobiotica; 1986 Apr; 16(4):335-40. PubMed ID: 3754997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of some conformationally rigid benzylamine analogs as substrates for rabbit lung N-methyltransferase.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1980 Dec; 30(3):401-8. PubMed ID: 7255857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of beclamide, N-benzyl-3-chloropropionamide, in man.
    Nicholls PJ; Ross MS; Luscombe DK
    Xenobiotica; 1979 Feb; 9(2):129-40. PubMed ID: 433311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and distribution of benzylamine in tissue extracts isolated from rats pretreated with pargyline.
    Durden DA; Philips ST; Boulton AA
    Biochem Pharmacol; 1976 Apr; 25(7):858-9. PubMed ID: 938586
    [No Abstract]   [Full Text] [Related]  

  • 13. The fate of saccharin impurities: the excretion and metabolism of [3-14C]Benz[d]-isothiazoline-1,1-dioxide (BIT) in man and rat.
    Renwick AG; Williams RT
    Xenobiotica; 1978 Aug; 8(8):475-86. PubMed ID: 695691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolism of dibenzylamine: identification of NN-dibenzylhydroxylamine as the major in vitro metabolic product from rabbit fortified hepatic homogenates.
    Beckett AH; Coutts RT; Gibson GG
    J Pharm Pharmacol; 1975 Sep; 27(9):659-65. PubMed ID: 241809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on anti-inflammatory agents. VI. Absorption, Excretion and metabolism of 2-amino-3-ethoxycarbonyl-6-benzyl(alpha-14C)-4,5,6,7-tetrahydrothieno(2,3-c)pyridine (14C-Y-3642) in mice].
    Imamura H; Matsui E; Kato Y
    Yakugaku Zasshi; 1970 Mar; 90(3):302-7. PubMed ID: 5464160
    [No Abstract]   [Full Text] [Related]  

  • 16. Hippuric acid synthesis in man after the administration of [alpha-14C]Glycine.
    BERLIN NI; HEWITT C; LOTZ C
    Biochem J; 1954 Nov; 58(3):498-503. PubMed ID: 13208642
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary studies on the fate of 14C-fentiazac in man.
    Franklin RA; Norris R; Shepherd NW; Rhenius ST
    Xenobiotica; 1984 Dec; 14(12):956-60. PubMed ID: 6531943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of some derivatives of piperidine, piperazine and related compounds on deamination of serotonin, tyramine and benzylamine by pig liver mitochondrial monoamine oxidase].
    Prikulis AA; Grinberga BA; Grinshteĭn VIa; Strelka GR
    Biokhimiia; 1983; 48(2):313-9. PubMed ID: 6838929
    [No Abstract]   [Full Text] [Related]  

  • 19. The cellular distribution of the metabolic deamination of benzylamine.
    Bélanger PM; Lalande M
    Life Sci; 1980 Jun; 26(24):2037-44. PubMed ID: 7392817
    [No Abstract]   [Full Text] [Related]  

  • 20. The disposition and metabolism of 14C-tiaramide . HCl in man.
    Klunk LJ; Riska PS; Maynard DE
    Drug Metab Dispos; 1982; 10(3):241-5. PubMed ID: 6125356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.